Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Oct 31, 2016 | $8.90B |
| FY2017, ended Oct 31, 2017 | $12.9B |
| FY2018, ended Oct 31, 2018 | $13.4B |
| FY2019, ended Oct 31, 2019 | $20.4B |
| FY2020, ended Oct 31, 2020 | $32.7B |
| FY2021, ended Oct 31, 2021 | $51.1B |
| FY2022, ended Oct 31, 2022 | $44.6B |
| FY2023, ended Oct 31, 2023 | $71.3B |
| FY2024, ended Oct 31, 2024 | $79.4B |
| FY2025, ended Oct 31, 2025 | $86.8B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $74.5B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Oct 31, 2016 | $2.42B |
| FY2017, ended Oct 31, 2017 | $2.72B |
| FY2018, ended Oct 31, 2018 | $3.12B |
| FY2019, ended Oct 31, 2019 | $3.36B |
| FY2020, ended Oct 31, 2020 | $3.69B |
| FY2021, ended Oct 31, 2021 | $4.20B |
| FY2022, ended Oct 31, 2022 | $5.08B |
| FY2023, ended Oct 31, 2023 | $5.32B |
| FY2024, ended Oct 31, 2024 | $6.13B |
| FY2025, ended Oct 31, 2025 | $7.05B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $9.42B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Oct 31, 2016 | $267M | $520M |
| FY2017, ended Oct 31, 2017 | $137M | $562M |
| FY2018, ended Oct 31, 2018 | $433M | $325M |
| FY2019, ended Oct 31, 2019 | $532M | $602M |
| FY2020, ended Oct 31, 2020 | $664M | $837M |
| FY2021, ended Oct 31, 2021 | $758M | $1.40B |
| FY2022, ended Oct 31, 2022 | $985M | $1.60B |
| FY2023, ended Oct 31, 2023 | $1.23B | $1.51B |
| FY2024, ended Oct 31, 2024 | $2.26B | $1.27B |
| FY2025, ended Oct 31, 2025 | $1.33B | $1.35B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $1.08B | $2.75B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Oct 31, 2016 | $977M |
| FY2017, ended Oct 31, 2017 | $1.05B |
| FY2018, ended Oct 31, 2018 | $723M |
| FY2019, ended Oct 31, 2019 | $729M |
| FY2020, ended Oct 31, 2020 | $1.24B |
| FY2021, ended Oct 31, 2021 | $1.43B |
| FY2022, ended Oct 31, 2022 | $1.42B |
| FY2023, ended Oct 31, 2023 | $1.43B |
| FY2024, ended Oct 31, 2024 | $3.90B |
| FY2025, ended Oct 31, 2025 | $2.89B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $3.61B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Oct 31, 2016 | $205M |
| FY2017, ended Oct 31, 2017 | $144M |
| FY2018, ended Oct 31, 2018 | $469M |
| FY2019, ended Oct 31, 2019 | $138M |
| FY2020, ended Oct 31, 2020 | $128M |
| FY2021, ended Oct 31, 2021 | $100M |
| FY2022, ended Oct 31, 2022 | $20.8M |
| FY2023, ended Oct 31, 2023 | $18.1M |
| FY2024, ended Oct 31, 2024 | $15.6M |
| FY2025, ended Oct 31, 2025 | $13.5B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $10.0B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 27.7% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Oct 31, 2016 | 150M |
| FY2017, ended Oct 31, 2017 | 149M |
| FY2018, ended Oct 31, 2018 | 150M |
| FY2019, ended Oct 31, 2019 | 151M |
| FY2020, ended Oct 31, 2020 | 153M |
| FY2021, ended Oct 31, 2021 | 153M |
| FY2022, ended Oct 31, 2022 | 152M |
| FY2023, ended Oct 31, 2023 | 152M |
| FY2024, ended Oct 31, 2024 | 155M |
| FY2025, ended Oct 31, 2025 | 191M |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | 192M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Used in acquisitions |
|---|---|---|---|
| FY2016, ended Oct 31, 2016 | $400M | $97.6M | — |
| FY2017, ended Oct 31, 2017 | $380M | $108M | — |
| FY2018, ended Oct 31, 2018 | $400M | $140M | — |
| FY2019, ended Oct 31, 2019 | $329M | $155M | — |
| FY2020, ended Oct 31, 2020 | $242M | $249M | — |
| FY2021, ended Oct 31, 2021 | $753M | $345M | — |
| FY2022, ended Oct 31, 2022 | $1.10B | $459M | — |
| FY2023, ended Oct 31, 2023 | $1.16B | $563M | — |
| FY2024, ended Oct 31, 2024 | $0 | $692M | — |
| FY2025, ended Oct 31, 2025 | $0 | $893M | $17.1B |
| Trailing 12 months to Jul 31, 2026 (through Q3 FY2026) | $300M | $950M | — |
Valuation
At current price- Market Cap
- $90.9B
- P/E
- 84.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 9.7×
- Price / Book
- 2.9×
- EV / EBITDA
- 37.2×
Growth
Trailing 12 months- Revenue (TTM)
- $9.42B
- Revenue Growth YoY
- 46.3%
- Revenue CAGR 3Y
- 11.6%
- Revenue CAGR 5Y
- 13.9%
- EPS Growth YoY
- −55.1%
- Net Income Growth YoY
- −46.1%
Profitability
Trailing 12 months- Gross Margin
- 72.4%
- Operating Margin
- 8.5%
- Net Margin
- 11.4%
- FCF Margin
- 29.2%
- Return on Equity
- 3.7%
Earnings
Trailing 12 months- Net Income
- $1.08B
- EPS (diluted)
- $5.72
- EBITDA
- $2.61B
- Operating Income
- $802M
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $3.61B
- Total Debt
- $10.0B
- Net Debt
- $6.43B
- Total Assets
- $47.7B
- Total Liabilities
- $16.6B
- Shareholders' Equity
- $31.2B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $2.94B
- Capital Expenditure
- $191M
- Free Cash Flow
- $2.75B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.21
Every ratio is calculated from the company’s reported figures.